Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Phase 2 Completed 36 enrolled City of Hope Medical Center National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using exemestane may fight breast cancer by lowering the amount of estrogen the body makes. PURPOSE: This phase II trial is studying how well exemestane works in treating postmenopausal women with stage IV breast cancer.

Timeline

Start: 2008-12-02
Primary completion: 2019-06-26
Completion: 2019-06-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Exemestane	Small molecule	—	Oral

Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer

Summary

Timeline

Drugs

Indications